Genetics and insurance: a possible solution

BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7293.1060/a (Published 28 April 2001) Cite this as: BMJ 2001;322:1060
  1. Virginia Warren, consultant in public health medicine. (warrenv@bupa.com)
  1. BUPA (British United Provident Association), BUPA House, London WC1A 2BA

    EDITOR—The interaction between clinical genetics and insurance is controversial. The remit of the government's Genetics and Insurance Committee is to assess the clinical and actuarial relevance of DNA test results to insurance practice. Its first ruling was that the industry could continue to use the results of DNA tests for Huntington's disease in underwriting applications for life insurance.

    One way of dispelling much of the controversy surrounding genetics and insurance would be to establish whether access to insurance is a …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription